Who makes Mitapivat coated granules?

Mitapivat coated granules is developed by Agios Pharmaceuticals, Inc..

What development phase is Mitapivat coated granules in?

Mitapivat coated granules is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Mitapivat coated granules

Agios Pharmaceuticals, Inc. · Phase 1 active Small molecule

At a glance

Generic name	Mitapivat coated granules
Also known as	AG-348, AG-348 sulfate hydrate, Mitapivat sulfate
Sponsor	Agios Pharmaceuticals, Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study to Assess the Relative Bioavailability and Effect of Food on the Coated Granule Formulation of Mitapivat in Healthy Participants (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Mitapivat coated granules CI brief — competitive landscape report
Mitapivat coated granules updates RSS · CI watch RSS
Agios Pharmaceuticals, Inc. portfolio CI